Hohl Benjamin

EDGAR CIK 0001882764

Enliven Therapeutics, Inc. - ELVN

  1. Manufacturing
  2. Chemicals
  3. Pharmaceutical Preparations
CFO
CHIEF FINANCIAL OFFICER
Direct Buys
0
$0
0 Shares
Direct Sells
2
($648,390)
-16,018 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
08/17/2026
10b5-1
08/19/2026
Sell
-6,018 @ $58.58
 ($352,551) 40,036 (-13.07%) Direct
03/06/2026
03/10/2026
Sell
-10,000 @ $29.58
 ($295,839) 51,000 (-16.39%) Direct